Endo profits plummet on Lidoderm settlement; Bipolar drugs to slide on generic competition;

 @FiercePharma: Fuji buys DKSH Thailand plant for $53 million. More | Follow @FiercePharma

> Endo Health Solutions ($ENDP) reported an 83% drop in net profits on a legal charge related to patent litigation over the Lidoderm pain patch. Report

> Sales of drugs for bipolar disorder are expected to slide over the next decade, despite an increasing number of patients, because of generic competition. Report

> Servier's Procoralan drug for heart failure won a recommendation from the U.K.'s cost-effectiveness watchdogs. Report

> India's Wockhardt reported a 97 increase in earnings and plans significant progress in paying down debt. Report | Report

> Boehringer Ingelheim's contract manufacturing division will turn out a new antibody-based drug for Servier and Xoma as the companies study it for inflammatory eye disease. Report

> Medicare beneficiaries won't see increased premiums for their Part D drug coverage this year, the Department of Health and Human Services said. Report

Medical Device News

@FierceMedDev:The plot thickens in the FDA's surveillance of whistleblowers. More | Follow @FierceMedDev

 @MarkHFierce: Abbott gained FDA approval for a new balloon-expandable stent system to treat iliac artery disease. Release | Follow @MarkHFierce

 @DamianFierce: Mindray Medical rides across-the-board sales growth to a big Q2. More | Follow @DamianFierce

> Device exec canned over Chick-fil-A outburst. More

> Cochlear profit plummets as firm plans implant relaunch. Story

> Sunshine Heart snags conditional approval for pump. Article

Biotech News

 @FierceBiotech: Brain signals when 'Special K' will do the trick. More | Follow @FierceBiotech

 @JohnCFierce: Elan now down 12% on bapi fiasco. So does the board have a short list of CEO candidates looking forward to a really tough challenge? | Follow @JohnCFierce

 @RyanMFierce: Not much left at biotech Agennix after talactoferrin failure. More | Follow @RyanMFierce

> Pluristem soars after stem cell drug aids recovery of cancer patient. More

> Bristol-Myers, others track tricky CGRP drug target to beat migraine. Article

> Pfizer, J&J kill PhIII program for key Alzheimer's drug. News

Biotech Research News

> Epilepsy drug boosts brain function in Alzheimer's preclinical tests. News

> HIV viral fragment delivers promising acute liver-failure treatment. Story

> Isis Pharmaceuticals' 'anti-sense' drug combats muscular dystrophy mice. More

> Teva's MLK inhibitor blocks aggressive breast cancer in MSU study. Article

Pharma Manufacturing News

> Manufacturing, pricing problems lead to K-V bankruptcy. Item

> Amneal doubling U.S. capacity, to add 500 jobs. News

> China sweeps in on drug counterfeiters. Report

> Fuji buys DKSH Thailand plant for $53M. News

And Finally ... As a Big Pharma Alzheimer's hopeful fails, scientists found that an FDA-approved seizure drug reversed memory loss in an animal model of the disease. Report